Harvard Bioscience EBITDA Margin 2010-2024 | HBIO

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Harvard Bioscience (HBIO) over the last 10 years. The current EBITDA margin for Harvard Bioscience as of December 31, 2024 is .
Harvard Bioscience EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-12-31 $0.10B $0.00B 2.11%
2024-09-30 $0.10B $0.00B 2.04%
2024-06-30 $0.10B $0.00B 2.97%
2024-03-31 $0.11B $0.01B 5.61%
2023-12-31 $0.11B $0.01B 8.93%
2023-09-30 $0.11B $0.01B 8.93%
2023-06-30 $0.11B $0.01B 6.14%
2023-03-31 $0.11B $0.01B 8.77%
2022-12-31 $0.11B $0.00B 0.88%
2022-09-30 $0.12B $0.00B 2.54%
2022-06-30 $0.12B $0.01B 5.79%
2022-03-31 $0.12B $0.00B 2.48%
2021-12-31 $0.12B $0.01B 8.40%
2021-09-30 $0.12B $0.01B 10.26%
2021-06-30 $0.11B $0.01B 10.81%
2021-03-31 $0.11B $0.01B 12.38%
2020-12-31 $0.10B $0.01B 9.80%
2020-09-30 $0.10B $0.01B 7.84%
2020-06-30 $0.11B $0.01B 6.67%
2020-03-31 $0.11B $0.01B 5.36%
2019-12-31 $0.12B $0.01B 7.76%
2019-09-30 $0.12B $0.01B 7.56%
2019-06-30 $0.12B $0.01B 9.09%
2019-03-31 $0.12B $0.01B 8.94%
2018-12-31 $0.12B $0.01B 8.20%
2018-09-30 $0.11B $0.01B 6.36%
2018-06-30 $0.10B $0.01B 5.00%
2018-03-31 $0.09B $0.00B 4.60%
2017-12-31 $0.08B $0.00B 5.13%
2017-09-30 $0.08B $0.00B 3.66%
2017-06-30 $0.09B $0.00B 2.27%
2017-03-31 $0.10B $0.00B 1.05%
2016-12-31 $0.10B $0.00B 0.96%
2016-09-30 $0.11B $0.00B 1.89%
2016-06-30 $0.11B $0.00B 1.87%
2016-03-31 $0.11B $0.00B 2.73%
2015-12-31 $0.11B $0.00B 1.83%
2015-09-30 $0.11B $0.00B 3.60%
2015-06-30 $0.11B $0.01B 5.45%
2015-03-31 $0.11B $0.01B 7.41%
2014-12-31 $0.11B $0.01B 9.26%
2014-09-30 $0.11B $0.01B 6.60%
2014-06-30 $0.11B $0.01B 5.66%
2014-03-31 $0.11B $0.01B 4.76%
2013-12-31 $0.11B $0.01B 4.76%
2013-09-30 $0.11B $0.01B 10.48%
2013-06-30 $0.11B $0.01B 10.38%
2013-03-31 $0.11B $0.01B 10.19%
2012-12-31 $0.11B $0.01B 10.00%
2012-09-30 $0.11B $0.01B 9.01%
2012-06-30 $0.11B $0.01B 9.01%
2012-03-31 $0.11B $0.01B 10.91%
2011-12-31 $0.11B $0.01B 12.04%
2011-09-30 $0.11B $0.01B 11.01%
2011-06-30 $0.11B $0.01B 12.84%
2011-03-31 $0.11B $0.01B 12.04%
2010-12-31 $0.11B $0.01B 12.96%
2010-09-30 $0.11B $0.01B 13.21%
2010-06-30 $0.10B $0.01B 13.86%
2010-03-31 $0.09B $0.01B 13.98%
2009-12-31 $0.09B $0.01B 13.95%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.016B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $6.101B 17.13
Kewaunee Scientific (KEQU) United States $0.103B 7.24